AN2 Therapeutics (ANTX) Return on Equity [ROE] (2022 - 2026)
AN2 Therapeutics' Return on Equity [ROE] was -46.01% in Q2 2026, up 6.57 percentage points from -52.58% a year earlier and up 5.25 percentage points from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at AN2 Therapeutics came in at -52.15%, down 2.45 percentage points from FY2024.
- Return on Equity [ROE] shows a three-year change of +118.45 percentage points (FY2022 to FY2025).
- In earlier years, Return on Equity [ROE] was -49.69% in FY2024 (+9.17 pp), -58.87% in FY2023 (+111.73 pp) and -170.60% in FY2022.
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2022.
- Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +2.63 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2023 (a gain of 24.32 percentage points); the worst was Q2 2023 (a drop of 37.65 percentage points).
- Per Business Quant data, ANTX's Return on Equity [ROE] in the three quarters before Q2 2026 was -51.26% (Q1 2026), -62.02% (Q4 2025) and -52.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | AN2 Therapeutics | 164.30 Mn | -121.79 Mn | - | -46.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -46.43% |
| Jun 30, 2026 | -46.07% |
| Mar 31, 2026 | -51.34% |
| Dec 31, 2025 | -61.97% |
| Sep 30, 2025 | -52.68% |
| Jun 30, 2025 | -52.51% |
| Mar 31, 2025 | -58.46% |
| Dec 31, 2024 | -60.84% |
| Sep 30, 2024 | -65.00% |
| Jun 30, 2024 | -61.80% |
| Mar 31, 2024 | -55.93% |
| Dec 31, 2023 | -48.61% |
| Sep 30, 2023 | -52.27% |
| Jun 30, 2023 | -63.50% |
| Mar 31, 2023 | -54.69% |
| Dec 31, 2022 | -41.11% |
| Sep 30, 2022 | -33.60% |
| Jun 30, 2022 | -28.21% |
| Mar 31, 2022 | -80.32% |
API Access
AN2 Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();